Breaking
Sign InSubscribe
HealthAI Central

Policy & Regulation

FDA clearances, CMS rulemakings, EU AI Act, and global health AI governance.

The FDA’s Bayesian Guidance Could Quietly Reshape Clinical Trial Design
Policy & Regulation

The FDA’s Bayesian Guidance Could Quietly Reshape Clinical Trial Design

HealthAI Central Editorial Team·June 18, 2026·4 min read
Why Drug Trials Are About to Get Smarter: FDA Embraces Statistical Revolution That Could Save Years of Research
Policy & Regulation

Why Drug Trials Are About to Get Smarter: FDA Embraces Statistical Revolution That Could Save Years of Research

HealthAI Central Editorial Team·June 17, 2026·4 min read
FDA Approves Australian Blowfly Larvae to Devour Dead Tissue in Chronic Wounds
Policy & Regulation

FDA Approves Australian Blowfly Larvae to Devour Dead Tissue in Chronic Wounds

HealthAI Central Editorial Team·June 16, 2026·4 min read
Government building with digital transformation overlay and AI interface elements
Policy & Regulation

FDA Launches Elsa 4.0 and HALO Platform to Modernize Internal AI Capabilities

The FDA has launched Elsa 4.0 and the HALO (Health AI and Learning Operations) platform, consolidating the agency's internal AI and data infrastructure to accelerate regulatory reviews and modernize how the agency processes scientific evidence.

HealthAI Central Editorial Team·May 9, 2026·4 min read